The Impact of Neoadjuvant Chemoradiotherapy on Perioperative Outcomes, Tumor Pathology, and Survival in Clinical Stage II and III Esophageal Cancer
Sheraz R. Markar MRCS, MSc, MA, Artur Bodnar MD, Joseph Rosales MD, Guobin Song MD, Donald E. Low FACS, FRCS(C)Volume:
20
Language:
english
DOI:
10.1245/s10434-013-3137-9
Date:
November, 2013
File:
PDF, 311 KB
english, 2013